A new advanced artificial intelligence (AI) algorithm more accurately model how genes associated with specific autoimmune diseases are expressed and regulated and to identify additional genes of risk.

HERSHEY, Pa. — A new advanced artificial intelligence (AI) algorithm may lead to better — and earlier — predictions and novel therapies for autoimmune diseases, which involve the immune system ...

Autoimmune rheumatic diseases (ARDs) represent a diverse group of conditions in which the immune system mistakenly targets the body’s own tissues, often affecting the musculoskeletal system and ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Autoimmune IVD Testing Market" report to their offering. This report provides important business planning information ...

New Rochelle, NY, October 3, 2018--A group of expert panelists gathered to discuss "Thyroid Immune Testing - Guidelines, Testing Platforms, and Clinical Impact on Women's Health." The informative and ...

Exagen Inc. (Nasdaq: XGN) is a leading provider of autoimmune diagnostics, committed to transforming care for patients with chronic and debilitating autoimmune conditions. Based in San Diego County, ...

SAN DIEGO, CA, March 16, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic ...

One growth driver includes the rising prevalence of autoimmune diseases. The global autoimmune disease testing market is estimated to reach $12.1b by 2033 at a compound annual growth rate of 8.6%, ...